東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Drug Repurposing Using Gene Expressi...

Qiu, Yue.

FindBook

Google Book

Amazon

博客來

Drug Repurposing Using Gene Expression Data Mining.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Drug Repurposing Using Gene Expression Data Mining./
作者:	Qiu, Yue.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2023,
面頁冊數:	111 p.
附註:	Source: Dissertations Abstracts International, Volume: 85-01, Section: B.
Contained By:	Dissertations Abstracts International85-01B.
標題:	Bioinformatics. -
電子資源:	https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30528375
ISBN:	9798379795498

Drug Repurposing Using Gene Expression Data Mining.
Qiu, Yue.

Drug Repurposing Using Gene Expression Data Mining. - Ann Arbor : ProQuest Dissertations & Theses, 2023 - 111 p.

Source: Dissertations Abstracts International, Volume: 85-01, Section: B.

Thesis (Ph.D.)--City University of New York, 2023.

The conventional drug discovery process that employs the "one disease, one target, one drug'' paradigm is expensive, time-consuming, and has a high rate of failure for multi-genic complex diseases. An alternative approach to drug discovery is to repurpose an existing drug that has been used to treat some medical conditions. Drug repurposing is considered a promising method due to its accelerated the process of drug discovery and lower overall cost and risk. Drug-perturbed gene expression profiles are powerful phenotype readouts of biological systems, and they have been widely used in drug repurposing studies. However, the existing drug-perturbed gene expression datasets are extremely noisy and the profiling is performed only in selected cell lines and compounds, limiting its applications to drug repurposing and compound screening. This thesis focuses on addressing those challenges---I have developed several novel computational methods and have demonstrated their powers in discovering novel therapeutics for multiple diseases.First, we have designed a Bayesian signature detection pipeline to process raw data from L1000 assays into robust z-scores. The pipeline produced drug signatures for in silico drug screening and repurposing with excellent accuracy and robustness. Based on these drug signatures, we have developed a phenotypic screening pipeline to repurpose Ibudilast and MK-2206 for Alzheimer's Disease.Second, we have employed machine learning models to predict gene expression patterns perturbed by new chemicals in new cell types. The predicted gene expression profiles are used for drug repurposing for COVID-19, pancreatic cancer, and Alzheimer's Disease, without prior experimental data. This method greatly expands the domain of in silico drug screening and phenotype-based drug repurposing. Third, I have applied the knowledge graph model to drug repurposing. The model integrates multiple sources of information from diverse biomedical databases, including genes, drugs, phenotypes, and patients. The knowledge graph embeddings provide representations of biological entities and knowledge, helping us to uncover the relationships between the drugs and diseases.Overall, this thesis presents novel approaches to drug repurposing that can lead to the discovery of new therapeutic options for various medical conditions, offering significant potential for improving patient care and reducing healthcare costs.

ISBN: 9798379795498Subjects--Topical Terms:

553671
Bioinformatics.
Subjects--Index Terms:

Data mining

Drug Repurposing Using Gene Expression Data Mining.
LDR:03546nmm a2200385 4500 001 2401080
005 20241015112517.5
006 m o d
007 cr#unu||||||||
008 251215s2023 ||||||||||||||||| ||eng d
020 $a 9798379795498
035 $a (MiAaPQ)AAI30528375
035 $a AAI30528375
035 $a 2401080
040 $a MiAaPQ $c MiAaPQ
100 1 $a Qiu, Yue. $3 3343189
245 1 0 $a Drug Repurposing Using Gene Expression Data Mining.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2023
300 $a 111 p.
500 $a Source: Dissertations Abstracts International, Volume: 85-01, Section: B.
500 $a Advisor: Xie, Lei.
502 $a Thesis (Ph.D.)--City University of New York, 2023.
520 $a The conventional drug discovery process that employs the "one disease, one target, one drug'' paradigm is expensive, time-consuming, and has a high rate of failure for multi-genic complex diseases. An alternative approach to drug discovery is to repurpose an existing drug that has been used to treat some medical conditions. Drug repurposing is considered a promising method due to its accelerated the process of drug discovery and lower overall cost and risk. Drug-perturbed gene expression profiles are powerful phenotype readouts of biological systems, and they have been widely used in drug repurposing studies. However, the existing drug-perturbed gene expression datasets are extremely noisy and the profiling is performed only in selected cell lines and compounds, limiting its applications to drug repurposing and compound screening. This thesis focuses on addressing those challenges---I have developed several novel computational methods and have demonstrated their powers in discovering novel therapeutics for multiple diseases.First, we have designed a Bayesian signature detection pipeline to process raw data from L1000 assays into robust z-scores. The pipeline produced drug signatures for in silico drug screening and repurposing with excellent accuracy and robustness. Based on these drug signatures, we have developed a phenotypic screening pipeline to repurpose Ibudilast and MK-2206 for Alzheimer's Disease.Second, we have employed machine learning models to predict gene expression patterns perturbed by new chemicals in new cell types. The predicted gene expression profiles are used for drug repurposing for COVID-19, pancreatic cancer, and Alzheimer's Disease, without prior experimental data. This method greatly expands the domain of in silico drug screening and phenotype-based drug repurposing. Third, I have applied the knowledge graph model to drug repurposing. The model integrates multiple sources of information from diverse biomedical databases, including genes, drugs, phenotypes, and patients. The knowledge graph embeddings provide representations of biological entities and knowledge, helping us to uncover the relationships between the drugs and diseases.Overall, this thesis presents novel approaches to drug repurposing that can lead to the discovery of new therapeutic options for various medical conditions, offering significant potential for improving patient care and reducing healthcare costs.
590 $a School code: 0046.
650 4 $a Bioinformatics. $3 553671
650 4 $a Pharmaceutical sciences. $3 3173021
650 4 $a Genetics. $3 530508
653 $a Data mining
653 $a Drug repurposing
653 $a Gene expreession
653 $a Therapeutics
690 $a 0715
690 $a 0369
690 $a 0572
710 2 $a City University of New York. $b Biology. $3 1025217
773 0 $t Dissertations Abstracts International $g 85-01B.
790 $a 0046
791 $a Ph.D.
792 $a 2023
793 $a English
856 4 0 $u https://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=30528375